See below for details of all PrecisionLife news, events and media activity as well as links to Disease Studies, research, and publications.
Festival of Genomics
Oxford, UK – We’ll be attending the Festival of Genomics on Jan 26-29 as the genomics and biodata ecosystems…
26/01/21
PrecisionLife lead panel session at Genesis Digital
Oxford, UK – PrecisionLife CEO Dr Steve Gardner chaired a fantastic panel session at Genesis2020 this week organised by…
10/12/20
BioIntegrates 2020
Oxford, UK – We’ll be at BioIntegrates on Nov 16th, a digital event focused on biotech, startups and emerging…
16/11/20
PrecisionLife joins EU endometriosis precision medicine consortium
Oxford, UK – PrecisionLife is part of a new £5.3m EU Horizon 2020 project that aims to develop precision…
3/02/21
PrecisionLife joins Genomics England’s Discovery Forum
Oxford, UK – PrecisionLife is now a member of Genomics England’s Discovery Forum, a network of organisations focused on…
2/11/20
PrecisionLife identified as leaders in fight against COVID-19 by Barclays Private Bank
Oxford, UK – PrecisionLife has been identified as a leader in the ongoing fight against COVID-19 by Barclays Private…
30/10/20
4D Meets AI partnering conference
Oxford, UK – We’ll be at LSci Nation’s 4D Meets AI partnering conference this week where we’ll be leading…
17/09/20
MedInvest AI, Big Data, Digital Health, and Telemedicine Conference
Oxford, UK – PrecisionLife CEO Dr Steve Gardner will be presenting at MedInvest’s virtual AI, Big Data, and Digital…
10/09/20
Startup Terrace Global Hack 2020
Oxford, UK – We’re supporting the Startup Terrace Global Hack 2020 – one of Taiwan’s truly international startup events…
9/09/20
Type-II Diabetes Complications
We built combinatorial risk scores that predict which type of complications a type-II diabetes patient is likely to experience.
8/01/21
Endometriosis
We stratified patients from UK Biobank and via combinatorial analysis identified 345 protein-coding genes strongly associated with disease risk.
16/03/21
Schizophrenia
We stratified a schizophrenia patient population to identify disease sub-groups and new targets for treatment responsive and resistant groups.
10/12/20
ALS Patient Stratification Analysis
We found 33 novel genes that were strongly associated with ALS and have selected 10 targets of significant interest for drug discovery screening.
9/12/20
Non-T2 (Non-Eosinophilic) Asthma
We revealed clear genetic differences between T2 / non-T2 asthma patients, leading to stratification biomarkers and novel, validated targets for non-T2 asthma.
10/12/20
Sjögren’s Syndrome
Identification of 299 risk-associated genes that are strongly associated with Sjögren’s syndrome.
23/03/21
Simon Beaulah joins PrecisionLife as SVP of Healthcare & Head of US Operations
Oxford, UK – PrecisionLife has appointed Simon Beaulah as SVP of Healthcare and Head of US Operations. Simon’s appointment…
9/09/20
Digital RESI event
Oxford, UK – We’ll be joining startups, technology partners and global investors at digital ‘Redefining Early Stage Investments’ (RESI)…
27/07/20
PrecisionLife CEO speaks to the 20/15 Visioneers Rock Stars podcast
Oxford, UK – PrecisionLife CEO Dr Steve Gardner was a guest on the thoroughly entertaining 20/15 Visioneers podcast last…
17/07/20